Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 4 recruiting now later-stage tilt

Colonoscopy: later-stage trial registry

4 of 21 indexed Colonoscopy trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #797 of 28,707 conditions by registered trial count.

21 US clinical trials · 4 currently recruiting · #797 of 28,707 conditions by registered trial count

Colonoscopy: 21 US clinical trials tracked, 4 recruiting.

Colonoscopy is the subject of 21 registered US clinical trials on ClinicalTrials.gov, 4 of them currently open to new participants. 7 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Braintree Laboratories, running 4 of these trials.

Enrollment posture brief

Registry condition colonoscopy

OPEN 4 | RECR 19% | LATE 7 | EARLY 2 | RANK #797 | SPON 4

Nearest open-share peer: Fatty Liver (19% recruiting · 21 trials)

Anal Cancer42.9%Colonoscopy (this)19%Allergic Conjunctivitis14.3%Attention Deficit Disorder W4.8%Adult Acute Myeloid Leukemia0%
Open-enrollment share among volume-matched conditions near Colonoscopy

Colonoscopy lists 4 open slots (19% of 21 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Colonoscopy on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Colonoscopy is recruiting below its size-band peers.

    4 of 21 indexed trials (19%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Colonoscopy research.

    Braintree Laboratories accounts for 4 of 21 trials (19%). 16 distinct sponsors appear on at least one study for this condition label.

  3. Typical Colonoscopy enrolment sits around 229 participants.

    Median target enrolment is 229 among the 21 trials that report a genuine target (sentinel values excluded). 3 of those (14.3%) plan for fewer than 100 participants.

  4. Colonoscopy research is mostly interventional.

    17 interventional and 4 observational studies make up this index (81% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 22Phase 35Phase 42

Open and recent trials

21 total, page 1 of 1

RECRUITING 2,700 participants

Can Overall Adenoma Detection Rate Replace Screening Adenoma Detection Rate ? Multicenter Study

Evergreen General Hospital, Taiwan

NCT05125939

RECRUITING 1,500 participants

Endoscopic Resection of Large Colorectal Polyps: An Observational Cohort Study

White River Junction Veterans Affairs Medical Center

NCT04220905

RECRUITING NA 180 participants

Impact of Artificial Intelligence on Trainee Polyp Miss Rates

Northwestern University

NCT06676930

RECRUITING Phase 4 100 participants

Can Nitrous Oxide (Laughing Gas) be Used as a Sedative for GI Endoscopy Procedures?

Stanford University

NCT05396144

ACTIVE NOT RECRUITING NA 990 participants

Cold Snare Endoscopic Mucosal Resection Trial

White River Junction Veterans Affairs Medical Center

NCT03865537

COMPLETED Phase 3 541 participants

A Safety Study of 3 Different Bowel Cleansing Preparations

Braintree Laboratories

NCT01501513

COMPLETED Phase 3 519 participants

Study 301: BLI4900 Versus an FDA-approved Comparator in Adult Subjects Prior to Colonoscopy

Braintree Laboratories

NCT04446299

COMPLETED NA 500 participants

Impact of a Novel Patient Educational Booklet on Colonoscopy Quality

VA Greater Los Angeles Healthcare System

NCT00975247

COMPLETED Phase 3 461 participants

A Phase III Study of the Efficacy and Safety of Remimazolam Compared to Placebo and Midazolam in Colonoscopy Patients

Paion UK

NCT02290873

COMPLETED 449 participants

Residual Gastric Volume in Same Day Versus Split Dose and Evening Before Bowel Preparation

The Cleveland Clinic

NCT02264249

COMPLETED Phase 4 425 participants

A Trial Comparing Split-Dose Miralax With Amitiza Pretreatment Versus Dulcolax Pretreatment Versus Golytely for Bowel Cleansing Prior to Colonoscopy

Brooke Army Medical Center

NCT00953017

COMPLETED Phase 3 400 participants

BLI-800-301: BLI-800 vs an Active Control Bowel Preparation in Adult Subjects Undergoing Colonoscopy

Braintree Laboratories

NCT00503607

COMPLETED NA 229 participants

Clinical Evaluation of Water Immersion Colonoscopy Insertion Technique

VA Palo Alto Health Care System

NCT00671177

COMPLETED Phase 3 200 participants

HalfLytely Bowel Prep System for Colonoscopy

Braintree Laboratories

NCT00164164

COMPLETED NA 200 participants

Morning-Only 4 L PEG vs Split Dose Prep for Afternoon Colonoscopies, Endoscopist-Blinded Prospective Study

The Cleveland Clinic

NCT02643316

COMPLETED NA 174 participants

Comparison of Oxygenation and Ventilation With a Novel Nasal Mask Versus Standard of Care During Colonoscopy

Vanderbilt University Medical Center

NCT03139448

COMPLETED 150 participants

New Bowel Preparation Scale for Measuring Colon Cleanliness

Gastroenterology Services

NCT01635725

COMPLETED NA 112 participants

CapsoCam® Colon Capsule Endoscope (CCE) Compared to Colonoscopy (OC)

Capso Vision

NCT04246632

COMPLETED NA 82 participants

EGD-assisted Bowel Preparation for Colonoscopy

Rockford Gastroenterology Associates

NCT01563744

COMPLETED Phase 2 80 participants

Evaluation of PillCam® Colon 2 Capsule Endoscopy Regimen

Medtronic - MITG

NCT01185002

COMPLETED Phase 2 40 participants

Safety, Efficacy, and Patient Preference of Split-Dose Crystalline Lactulose as a Preparation for Colonoscopy in Adults

Benaroya Research Institute

NCT01650870

Phase Distribution

PhaseTrial count
Phase 2 2
Phase 3 5
Phase 4 2

Named interventions

Most-linked intervention names on Colonoscopy records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

PillCam® COLON 2 procedure using reduced dose of Suprep boosts Other
1 trials
PillCam® COLON 2 procedure using Suprep boosts Other
1 trials
PillCam® COLON 2 procedure using MgC boosts Other
1 trials
Receiving an educational booklet Other
1 trials
BLI800 investigational preparation regimen Drug
1 trials
BLI800 approved preparation regimen Drug
1 trials
PEG-3350 based bowel preparation Drug
1 trials
Control Group received standard prep by oral administration Procedure
1 trials

US sites by state

Facility locations filed on Colonoscopy trials. A trial with sites in several states counts in each.

California 8 trials
Florida 6 trials
Alabama 5 trials
Virginia 4 trials
Tennessee 4 trials
North Carolina 4 trials
Louisiana 4 trials
Indiana 4 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Colonoscopy page

21 registered trials, 4 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Colonoscopy condition card totals 21 registered trials; most-linked intervention PillCam® COLON 2 procedure using reduced dose of Suprep boosts; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.